Pfizer posted sales of $12.69 billion in the fourth quarter, compared to $13.98 billion in sales in the same period one year prior.
Pfizer’s Upjohn unit, which includes Lyrica and the erectile dysfunction pill Viagra, saw its sales decline 32 percent in the fourth quarter. Lyrica in particular saw sales sink 68 percent due to competition from generics, according to CNBC.
Overall in the fourth quarter, the drugmaker reported a net loss of $337 million,compared to a loss of $394 million in the same period last year.
Pfizer’s Upjohn unit is merging with Mylan to form a new pharmaceutical company. That transaction is expected to close later this year.
More articles on pharmacy:
Drug shortages update: 5 things to know
Grocery store pharmacies across the country finding it harder to stay in business
AbbVie to donate $1M of drug China says will combat coronavirus